Back
Spyre Therapeutics Vs. Nike Industry Stock Comparison
Sell
20
SYRE
Spyre Therapeutics
Last Price:
23.64
Seasonality Move:
4.25%
Sell
27
NKE
Nike
Last Price:
75.36
Seasonality Move:
5.79%
Sell
20
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $23.60. The Score for SYRE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $75.37. The Score for NKE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $23.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKE Stock Price Chart
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.25 | Sell |
Relative Strength Index (14 RSI): | 32.2 | Sell |
Chaikin Money Flow: | 1227739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.55 - 35.81) | Sell |
Bollinger Bands (100): | (26.93 - 39.25) | Sell |
NKE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.17 | Sell |
Relative Strength Index (14 RSI): | 18.26 | Sell |
Chaikin Money Flow: | -81897721 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (89.64 - 97.74) | Sell |
Bollinger Bands (100): | (90.8 - 101.2) | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.04 | Sell |
20-day SMA: | 30.11 | Sell |
50-day SMA: | 32.97 | Sell |
200-day SMA: | 24.6 | Sell |
8-day EMA: | 24.78 | Sell |
20-day EMA: | 28.36 | Sell |
50-day EMA: | 31.48 | Sell |
200-day EMA: | 26.94 | Sell |
NKE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.88 | Sell |
20-day SMA: | 94.1 | Sell |
50-day SMA: | 93.36 | Sell |
200-day SMA: | 100.21 | Sell |
8-day EMA: | 90.62 | Sell |
20-day EMA: | 92.85 | Sell |
50-day EMA: | 93.83 | Sell |
200-day EMA: | 99.73 | Sell |
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.48 per share, and a decrease next year of $0.37 per share.
Spyre Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nike Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |